title: Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Complications of HIV disease and therapy.
abstract: Managing and preventing complications of HIV disease remain high priorities for research worldwide. At the 15th Conference on Retroviruses and Opportunistic Infections, continued areas of focus were on understanding the pathogenesis of complications, identifying risk factors for these problems, and defining optimal management strategies for complications and infections. As in past years, there was an increase in studies focused on problems predominantly occurring in resource-limited settings.
authors.affiliation: University of California Los Angeles and UCLA Center for Clinical AIDS Research and Education, Los Angeles, CA, USA.
authors.forename: Judith S
authors.initials: JS
authors.lastname: Currier
authors.forename: Diane V
authors.initials: DV
authors.lastname: Havlir
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000401:mortality / Q000517:prevention & control; D000375:Aging; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000209:etiology / Q000628:therapy; D050171:Dyslipidemias / Q000209:etiology / Q000628:therapy; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D039682:HIV-Associated Lipodystrophy Syndrome / Q000628:therapy; D006526:Hepatitis C / Q000628:therapy; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000628:therapy; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy
chemical_list: D019380:Anti-HIV Agents